Page 1205 - Williams Hematology ( PDFDrive )
P. 1205
1180 Part IX: Lymphocytes and Plasma Cells Chapter 76: Functions of T Lymphocytes: T-cell Receptors for Antigen 1181
normally constitute 25 to 35 percent of the peripheral T-cell popula- response becomes increasingly polarized once it develops along a Th1
tion. They recognize antigens presented by MHC class I molecules and or Th2 pathway, particularly upon protracted stimulation by chronic
differentiate into cytotoxic CD8 T cells. Their main function is lysis of infection or prolonged exposure to environmental antigens. Other fac-
the target cell bearing the surface antigens for which a cytotoxic T cell tors that drive polarization are chemokines (explaining the differential
is specific. Within this subset, there are a range of phenotypes defined expression of chemokine receptors on Th1/Th2 cells), eicosanoids, oxy-
both by function and expression of markers with an immunoregula- gen free radicals, various inflammatory mediators, and direct cell-to-
tory function. Blood T cells that solely express the CD4 surface antigen cell interaction with APCs.
are designated helper T cells. They normally comprise approximately Functionally, Th1 cells predominantly drive cellular immunity to
65 percent of blood T cells. Generally, their function is the production fight viruses and other intracellular pathogens, eliminate cancerous
of lymphokines upon activation by foreign antigens presented by MHC cells, and stimulate delayed-type hypersensitivity (DTH) skin reac-
class II molecules, regulating and/or assisting in the active immune tions. This is mostly achieved by stimulating macrophage Fc receptor
response. Helper T cells can differentiate into several subtypes, each expression, phagocytosis, and antigen presentation, enhancing the
secreting different cytokines to facilitate a different type of immune capacity of macrophages to kill intracellular pathogens. Th2 cells drive
response. humoral immunity and upregulate antibody production to fight extra-
cellular organisms. They initiate the antibody response to antigen by
activating naïve antigen-specific B cells to produce IgM antibodies,
CD4+ T-CELL SUBSETS subsequently stimulate the production of switched immunoglobulin
Th1 and Th2 Cells isotypes, including IgA, IgE, and neutralize and/or weakly opsonize
Based on distinct cytokine patterns upon activation, mature CD4+ subtypes of IgG (Chap. 75), probably via IL-4 as a B-cell stimulatory/
T cells may be divided into subsets–the first of which identified were growth factor. In addition to stimulating the production of IgE antibod-
named T-helper type 1 (Th1) and T-helper type 2 (Th2). In general, Th1 ies, the cytokines made by Th2 cells induce differentiation of mast cells
34
cells are a major source of interferon-γ (IFN-γ), and also the major T-cell and eosinophils. 34
population involved in activating macrophages and clearing intracellu- Several studies have indicated that Th2 polarization and accu-
lar pathogens. Th2 cells are a major source of IL-4 and are important mulation at inflammatory sites is likely to trigger the hypersensitiv-
41
for the generation of immunoglobulin (Ig) E, the production of eosin- ity reaction in allergic diseases. On the other hand, these responses
ophils, and the immune defense against infections by parasites. Both are protective against metazoan parasite infections such as helminths:
subsets are produced from a noncommitted population of precursor Th2 responses are host protective while extracellular parasites migrate
T cells. The process by which commitment develops is called through the body, and reduce the number of parasites either through
42
polarization. direct killing in the tissues or expulsion from the intestines. Other
In addition to IFN-γ, Th1 cells produce lymphotoxin β, IL-2, and studies demonstrate that eosinophilia and elevated IgE that accompany
IL-12, whereas Th2 cells also produce IL-5, IL-13, and IL-25. Human infection with Schistosoma mansoni are caused by the induction of
43
Th1 and Th2 cells can also differ in the array of surface antigens or cytok- Th2-type cells in the immune response to parasite ova. The Th2 polar-
ine receptors they express. Th1 cells preferentially express CD26, mem- ization in these diseases/conditions is most likely a result of minimal
brane IFN-γ, the chemokine receptors CCR1 (CD191), CCR2 (CD192), IL-4 secretion during initial activation. If an antigen is present at high
CCR5 (CD195), CXCR3 (CD183), and CXCR6 (CD186), and the recep- concentrations but does not trigger acute inflammation and attendant
tor for IL-12 (IL-12R or CD212). Higher levels of the lymphocyte acti- production of IL-12, the local concentration of IL-4 increases over time
vation gene 3 (LAG-3 or CD223), a ligand for MHC class II antigens and induces a Th2 polarization of cells. On the other hand, pathogens
that is structurally related to CD4, have also been described. Th2 cells that induce acute inflammation and/or engage toll-like receptors on
preferentially express CD62L, the α chain of the IL-4 receptor (IL-4Rα), accessory cells and macrophages can promote production of IFN-γ and
the α chain of the IL-33 receptor (IL-33Rα), CD30, and the chemokine IL-12, thereby stimulating development of the immune response along
38
receptors CCR3 (CD193), CCR4 (CD194), CCR8 (CDw198), and, to the Th1 pathway. Immune responses restricted to Th1 cells, for exam-
some extent, CXCR4 (CD184). 35–37 Distinctive expression levels of these ple, are observed in patients with leprosy who have developed cellular
44
45
cytokine and chemokine receptors, along with distinctive binding activ- immunity to Mycobacterium leprae or M. tuberculosis, in patients
46
ities for various endothelial selectins, most likely account for the differ- with Yersinia enterocolitica or arthritis triggered by infection with
ences in the response to cytokines and tissue-specific migration of these Borrelia burgdorferi. 47
helper T-cell subsets. However, it is probably overly simplistic to view the Th1 pathway
The cytokines produced by each subset also stimulate polariza- as being the more aggressive of the two, generating acute organ-
tion of additional T cells to the same subset, while inhibiting the polar- specific autoimmune diseases and inflammations, while the Th2 path-
ization of the other subset. In naïve CD4+ T cells, the Th1 cytokine way predisposes to atopic diseases and systemic autoimmune disease.
IFN-γ induces or activates the signal transducer and activator of tran- For example, Helicobacter pylori-associated peptic ulcer can be regarded
scription (STAT) 1, STAT4, and the T-box transcription factor T-BET, as a Th1-driven immunopathologic response to some H. pylori antigens,
while simultaneously modulating IL-2 and Th2 cytokines, resulting while deregulated and exhaustive H. pylori-induced T-cell–dependent
48
in an attenuation of Th2 cell development (Fig. 76–3). Several other B-cell activation can support the onset of low-grade B-cell lymphoma.
38
studies demonstrate that T-BET also physically interacts with other In addition, many chronic inflammatory and autoimmune conditions
transcription factors important for alternative T helper cell develop- such as rheumatoid arthritis (RA), type 1 diabetes, and multiple scle-
mental decisions to functionally repress the opposing subtype specific rosis (MS) are mixed Th1/Th2 conditions, and a clear Th1/Th2 bias has
gene expression programs and promote Th1 development. Similarly, also not been identified yet for many types of cancer. 34
39
IL-4 activates or enhances the expression STAT5, STAT6, and GATA3,
transcription factors that play important roles in Th2 cell development CD4+CD25+ Regulatory T Cells
(Fig. 76–3). Another Th2 cytokine, IL-10, inhibits Th1 cell activation, Another type of CD4 cells that suppresses rather than provides helper
40
thereby limiting the production of Th1-type cytokines. Because of these activity are regulatory T (T REG ) cells. T REGs possess potent suppressive
self-amplifying and mutually excluding feedback loops, an immune capacity and can exert diverse suppressive mechanisms allowing them
Kaushansky_chapter 76_p1175-1188.indd 1180 9/17/15 4:01 PM

